Cited by 360Amyotrophic Lateral Sclerosis ResearchExtracellular vesicles in diseaseAlzheimer's disease research and treatments

Exosome secretion is a key pathway for clearance of pathological TDP-43

Open access
Iguchi, Yohei, Eid, Lara, Parent, Martin, Soucy, Geneviève, Bareil, Christine, Riku, Yuichi, Kawai, Kaori, Takagi, Shinnosuke +4 more·2016·Brain

Abstract

mutant. Thus, even though results suggest that exosomes containing pathological TDP-43 may play a key role in the propagation of TDP-43 proteinopathy, a therapeutic strategy for amyotrophic lateral sclerosis based on inhibition of exosome production would seem inappropriate, as in vivo data suggest that exosome secretion plays an overall beneficial role in neuronal clearance of pathological TDP-43.

Integrity signals

Registry

Crossref · 10.1093/brain/aww237

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iguchi, Y., Eid, L., Parent, M., Soucy, G., Bareil, C., Riku, Y., Kawai, K., Takagi, S., Yoshida, M., Katsuno, M., Sobue, G., & Julien, J.-P.
Affiliations
  • Institut Universitaire en Santé Mentale de Québec (CA)
  • Nagoya University (JP)
  • Aichi Medical University (JP)
Corresponding author
Julien, Jean-Pierre
Venue
Brain
Published
2016-09-27
Volume
139
Issue
12
Pages
3187-3201
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2524787240
Cited by
360
References
6
Citations by year
2026: 24 · 2025: 46 · 2024: 43 · 2023: 35 · 2022: 38 · 2021: 56 · 2020: 52 · 2019: 23 · 2018: 26 · 2017: 16 · 2016: 1
FWCI
16.54
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Canadian Institutes of Health Research
  • Japan Society for the Promotion of Science (26461269, 26293206, 16K15480, 26117002, 26117001)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
exosome secretion, TDP-43, amyotrophic lateral sclerosis
MeSH terms
Aniline Compounds, Animals, Behavior, Animal, Benzylidene Compounds, Cell Line, Disease Models, Animal, DNA-Binding Proteins, Humans, Mice, Transgenic, Sphingomyelin Phosphodiesterase, Mice, Exosomes, TDP-43 Proteinopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review